Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price-Reference-Cited by-同舟云学术

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price

Published:2021-06 Issue:6 Volume:17 Page:335-342
ISSN:1699-258X
Container-title:Reumatología Clínica
language:en
Short-container-title:Reumatología Clínica

Author:

González Fernández Mariángeles^ORCID,Villamañán Elena^ORCID,Jiménez-Nácher Inmaculada^ORCID,Moreno Francisco^ORCID,Plasencia Chamaida^ORCID,Gayá Francisco^ORCID,Herrero Alicia^ORCID,Balsa Alejandro^ORCID

Publisher

Elsevier BV

Subject

Rheumatology

Reference31 articles.

1. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis;Gibofsky;Am J Manag Care,2014

2. Epidemiology and burden of illness of rheumatoid arthritis;Kvien;PharmacoEconomics,2004

3. The prevalence of rheumatoid arthritis in the general population of Spain;Carmona;Rheumatol Oxf Engl,2002

4. Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany;Gissel;Z Rheumatol,2016

5. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Rheumatol Hoboken NJ,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers;Exploration of Musculoskeletal Diseases;2024-09-10

2. Action of Tofacitinib in a Rat Model of Synovitis;Journal of Biomaterials and Tissue Engineering;2022-10-01

3. The role of the pharmacist within an immune-mediated inflammatory disease unit: Results of a survey of healthcare providers and patients;FARM HOSP;2021

4. One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry;Rheumatology International;2021-01-02